+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pneumonia Vaccines Market (2019-2025)

  • ID: 4801480
  • Report
  • June 2019
  • Region: Global
  • 243 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

FEATURED COMPANIES

  • LG Corporation
  • Merck & Co., Inc.
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • SK Holdings Co., Ltd.
  • MORE
The Global Pneumonia Vaccines Market size is expected to reach $9.6 billion by 2025, rising at a market growth of 5.1% CAGR during the forecast period.

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs thereby filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at the greatest risk of serious pneumococcal infections and even death. Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that cause infection in the lungs.

The key factors that drive the growth of the global pneumonia vaccine market include an increase in the prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10. However, longer timelines required for pneumonia vaccine production and high costs associated with the development of such vaccines restrain the market growth.

Based on Vaccine Type, the market is segmented into Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV). Based on Product Type, the market is segmented into Prevnar 13, Synflorix and Pneumovax23. According to sector, the market is segmented into Public sector and Private sector. Based on Distribution Channel, the market is further segmented into Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.

Scope of the Study

Market Segmentation:

By Vaccine Type
  • Pneumococcal conjugate vaccine (PCV)
  • Pneumococcal polysaccharide vaccine (PPSV/PPV)
By Product Type
  • Prevnar 13
  • Synflorix
  • Pneumovax23
By Sector
  • Public sector
  • Private sector
By Distribution Channel
  • Distribution partner companies
  • Non-governmental Organizations (NGO)
  • Government Authorities
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Glaxosmithkline Plc. (GSK)
  • LG Corporation
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Holdings Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • LG Corporation
  • Merck & Co., Inc.
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • SK Holdings Co., Ltd.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Pneumonia Vaccines Market, by Vaccine Type
1.4.2 Global Pneumonia Vaccines Market, by Product Type
1.4.3 Global Pneumonia Vaccines Market, by Sector
1.4.4 Global Pneumonia Vaccines Market, by Distribution Channel
1.4.5 Global Pneumonia Vaccines Market, by Region
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Pneumonia Vaccines Market by Vaccine Type
3.1 Global Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 Global Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region

Chapter 4. Global Pneumonia Vaccines Market by Product Type
4.1 Global Prevnar 13 Market by Region
4.2 Global Synflorix Market by Region
4.3 Global Pneumovax 23 Market by Region

Chapter 5. Global Pneumonia Vaccines Market by Sector
5.1 Global Private sector Market by Region
5.2 Global Public sector Market by Region

Chapter 6. Global Pneumonia Vaccines Market by Distribution Channel
6.1 Global Distribution Partner Companies Market by Region
6.2 Global Non-Governmental Organizations (NGO) Market by Region
6.3 Global Government Authorities Market by Region

Chapter 7. Global Pneumonia Vaccines Market by Region
7.1 North America Pneumonia Vaccines Market
7.1.1 North America Pneumonia Vaccines Market by Vaccine Type
7.1.1.1 North America Pneumococcal Conjugate Vaccine (PCV) Market by Region
7.1.1.2 North America Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
7.1.2 North America Pneumonia Vaccines Market by Product Type
7.1.2.1 North America Prevnar 13 Market by Region
7.1.2.2 North America Synflorix Market by Region
7.1.2.3 North America Pneumovax 23 Market by Region
7.1.3 North America Pneumonia Vaccines Market by Sector
7.1.3.1 North America Private sector Market by Region
7.1.3.2 North America Public sector Market by Region
7.1.4 North America Pneumonia Vaccines Market by Distribution Channel
7.1.4.1 North America Distribution Partner Companies Market by Region
7.1.4.2 North America Non-Governmental Organizations (NGO) Market by Region
7.1.4.3 North America Government Authorities Market by Region
7.1.5 North America Pneumonia Vaccines Market by Region
7.1.5.1 USA Pneumonia Vaccines Market
7.1.5.1.1 USA Pneumonia Vaccines Market by Vaccine Type
7.1.5.1.2 USA Pneumonia Vaccines Market by Product Type
7.1.5.1.3 USA Pneumonia Vaccines Market by Sector
7.1.5.1.4 USA Pneumonia Vaccines Market by Distribution Channel
7.1.5.2 Canada Pneumonia Vaccines Market
7.1.5.2.1 Canada Pneumonia Vaccines Market by Vaccine Type
7.1.5.2.2 Canada Pneumonia Vaccines Market by Product Type
7.1.5.2.3 Canada Pneumonia Vaccines Market by Sector
7.1.5.2.4 Canada Pneumonia Vaccines Market by Distribution Channel
7.1.5.3 Mexico Pneumonia Vaccines Market
7.1.5.3.1 Mexico Pneumonia Vaccines Market by Vaccine Type
7.1.5.3.2 Mexico Pneumonia Vaccines Market by Product Type
7.1.5.3.3 Mexico Pneumonia Vaccines Market by Sector
7.1.5.3.4 Mexico Pneumonia Vaccines Market by Distribution Channel
7.1.5.4 Rest of North America Pneumonia Vaccines Market
7.1.5.4.1 Rest of North America Pneumonia Vaccines Market by Vaccine Type
7.1.5.4.2 Rest of North America Pneumonia Vaccines Market by Product Type
7.1.5.4.3 Rest of North America Pneumonia Vaccines Market by Sector
7.1.5.4.4 Rest of North America Pneumonia Vaccines Market by Distribution Channel
7.2 Europe Pneumonia Vaccines Market
7.2.1 Europe Pneumonia Vaccines Market by Vaccine Type
7.2.1.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market by Region
7.2.1.2 Europe Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
7.2.2 Europe Pneumonia Vaccines Market by Product Type
7.2.2.1 Europe Prevnar 13 Market by Region
7.2.2.2 Europe Synflorix Market by Region
7.2.2.3 Europe Pneumovax 23 Market by Region
7.2.3 Europe Pneumonia Vaccines Market by Sector
7.2.3.1 Europe Private sector Market by Region
7.2.3.2 Europe Public sector Market by Region
7.2.4 Europe Pneumonia Vaccines Market by Distribution Channel
7.2.4.1 Europe Distribution Partner Companies Market by Region
7.2.4.2 Europe Non-Governmental Organizations (NGO) Market by Region
7.2.4.3 Europe Government Authorities Market by Region
7.2.5 Europe Pneumonia Vaccines Market by Region
7.2.5.1 Germany Pneumonia Vaccines Market
7.2.5.1.1 Germany Pneumonia Vaccines Market by Vaccine Type
7.2.5.1.2 Germany Pneumonia Vaccines Market by Product Type
7.2.5.1.3 Germany Pneumonia Vaccines Market by Sector
7.2.5.1.4 Germany Pneumonia Vaccines Market by Distribution Channel
7.2.5.2 UK Pneumonia Vaccines Market
7.2.5.2.1 UK Pneumonia Vaccines Market by Vaccine Type
7.2.5.2.2 UK Pneumonia Vaccines Market by Product Type
7.2.5.2.3 UK Pneumonia Vaccines Market by Sector
7.2.5.2.4 UK Pneumonia Vaccines Market by Distribution Channel
7.2.5.3 France Pneumonia Vaccines Market
7.2.5.3.1 France Pneumonia Vaccines Market by Vaccine Type
7.2.5.3.2 France Pneumonia Vaccines Market by Product Type
7.2.5.3.3 France Pneumonia Vaccines Market by Sector
7.2.5.3.4 France Pneumonia Vaccines Market by Distribution Channel
7.2.5.4 Russia Pneumonia Vaccines Market
7.2.5.4.1 Russia Pneumonia Vaccines Market by Vaccine Type
7.2.5.4.2 Russia Pneumonia Vaccines Market by Product Type
7.2.5.4.3 Russia Pneumonia Vaccines Market by Sector
7.2.5.4.4 Russia Pneumonia Vaccines Market by Distribution Channel
7.2.5.5 Spain Pneumonia Vaccines Market
7.2.5.5.1 Spain Pneumonia Vaccines Market by Vaccine Type
7.2.5.5.2 Spain Pneumonia Vaccines Market by Product Type
7.2.5.5.3 Spain Pneumonia Vaccines Market by Sector
7.2.5.5.4 Spain Pneumonia Vaccines Market by Distribution Channel
7.2.5.6 Italy Pneumonia Vaccines Market
7.2.5.6.1 Italy Pneumonia Vaccines Market by Vaccine Type
7.2.5.6.2 Italy Pneumonia Vaccines Market by Product Type
7.2.5.6.3 Italy Pneumonia Vaccines Market by Sector
7.2.5.6.4 Italy Pneumonia Vaccines Market by Distribution Channel
7.2.5.7 Rest of Europe Pneumonia Vaccines Market
7.2.5.7.1 Rest of Europe Pneumonia Vaccines Market by Vaccine Type
7.2.5.7.2 Rest of Europe Pneumonia Vaccines Market by Product Type
7.2.5.7.3 Rest of Europe Pneumonia Vaccines Market by Sector
7.2.5.7.4 Rest of Europe Pneumonia Vaccines Market by Distribution Channel
7.3 Asia Pacific Pneumonia Vaccines Market
7.3.1 Asia Pacific Pneumonia Vaccines Market by Type
7.3.1.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market by Region
7.3.1.2 Asia Pacific Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
7.3.2 Asia Pacific Pneumonia Vaccines Market by Product Type
7.3.2.1 Asia Pacific Prevnar 13 Market by Region
7.3.2.2 Asia Pacific Synflorix Market by Region
7.3.2.3 Asia Pacific Pneumovax 23 Market by Region
7.3.3 Asia Pacific Pneumonia Vaccines Market by Sector
7.3.3.1 Asia Pacific Public sector Market by Region
7.3.3.2 Asia Pacific Private sector Market by Region
7.3.4 Asia Pacific Pneumonia Vaccines Market by Distribution Channel
7.3.4.1 Asia Pacific Distribution Partner Companies Market by Region
7.3.4.2 Asia Pacific Non-Governmental Organizations (NGO) Market by Region
7.3.4.3 Asia Pacific Government Authorities Market by Region
7.3.5 Asia Pacific Pneumonia Vaccines Market by Region
7.3.5.1 China Pneumonia Vaccines Market
7.3.5.1.1 China Pneumonia Vaccines Market by Type
7.3.5.1.2 China Pneumonia Vaccines Market by Product Type
7.3.5.1.3 China Pneumonia Vaccines Market by Sector
7.3.5.1.4 China Pneumonia Vaccines Market by Distribution Channel
7.3.5.2 Japan Pneumonia Vaccines Market
7.3.5.2.1 Japan Pneumonia Vaccines Market by Type
7.3.5.2.2 Japan Pneumonia Vaccines Market by Product Type
7.3.5.2.3 Japan Pneumonia Vaccines Market by Sector
7.3.5.2.4 Japan Pneumonia Vaccines Market by Distribution Channel
7.3.5.3 India Pneumonia Vaccines Market
7.3.5.3.1 India Pneumonia Vaccines Market by Type
7.3.5.3.2 India Pneumonia Vaccines Market by Product Type
7.3.5.3.3 India Pneumonia Vaccines Market by Sector
7.3.5.3.4 India Pneumonia Vaccines Market by Distribution Channel
7.3.5.4 South Korea Pneumonia Vaccines Market
7.3.5.4.1 South Korea Pneumonia Vaccines Market by Type
7.3.5.4.2 South Korea Pneumonia Vaccines Market by Product Type
7.3.5.4.3 South Korea Pneumonia Vaccines Market by Sector
7.3.5.4.4 South Korea Pneumonia Vaccines Market by Distribution Channel
7.3.5.5 Singapore Pneumonia Vaccines Market
7.3.5.5.1 Singapore Pneumonia Vaccines Market by Type
7.3.5.5.2 Singapore Pneumonia Vaccines Market by Product Type
7.3.5.5.3 Singapore Pneumonia Vaccines Market by Sector
7.3.5.5.4 Singapore Pneumonia Vaccines Market by Distribution Channel
7.3.5.6 Malaysia Pneumonia Vaccines Market
7.3.5.6.1 Malaysia Pneumonia Vaccines Market by Type
7.3.5.6.2 Malaysia Pneumonia Vaccines Market by Product Type
7.3.5.6.3 Malaysia Pneumonia Vaccines Market by Sector
7.3.5.6.4 Malaysia Pneumonia Vaccines Market by Distribution Channel
7.3.5.7 Rest of Asia Pacific Pneumonia Vaccines Market
7.3.5.7.1 Rest of Asia Pacific Pneumonia Vaccines Market by Type
7.3.5.7.2 Rest of Asia Pacific Pneumonia Vaccines Market by Product Type
7.3.5.7.3 Rest of Asia Pacific Pneumonia Vaccines Market by Sector
7.3.5.7.4 Rest of Asia Pacific Pneumonia Vaccines Market by Distribution Channel
7.4 LAMEA Pneumonia Vaccines Market
7.4.1 LAMEA Pneumonia Vaccines Market by Vaccine Type
7.4.1.1 LAMEA Pneumococcal Conjugate Vaccine (PCV) Market by Region
7.4.1.2 LAMEA Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
7.4.2 LAMEA Pneumonia Vaccines Market by Product Type
7.4.2.1 LAMEA Prevnar 13 Market by Region
7.4.2.2 LAMEA Synflorix Market by Region
7.4.2.3 LAMEA Pneumovax 23 Market by Region
7.4.3 LAMEA Pneumonia Vaccines Market by Sector
7.4.3.1 LAMEA Private sector Market by Region
7.4.3.2 LAMEA Public sector Market by Region
7.4.4 LAMEA Pneumonia Vaccines Market by Distribution Channel
7.4.4.1 LAMEA Distribution Partner Companies Market by Region
7.4.4.2 LAMEA Non-Governmental Organizations (NGO) Market by Region
7.4.4.3 LAMEA Government Authorities Market by Region
7.4.5 LAMEA Pneumonia Vaccines Market by Region
7.4.5.1 Brazil Pneumonia Vaccines Market
7.4.5.1.1 Brazil Pneumonia Vaccines Market by Vaccine Type
7.4.5.1.2 Brazil Pneumonia Vaccines Market by Product Type
7.4.5.1.3 Brazil Pneumonia Vaccines Market by Sector
7.4.5.1.4 Brazil Pneumonia Vaccines Market by Distribution Channel
7.4.5.2 Argentina Pneumonia Vaccines Market
7.4.5.2.1 Argentina Pneumonia Vaccines Market by Vaccine Type
7.4.5.2.2 Argentina Pneumonia Vaccines Market by Product Type
7.4.5.2.3 Argentina Pneumonia Vaccines Market by Sector
7.4.5.2.4 Argentina Pneumonia Vaccines Market by Distribution Channel
7.4.5.3 UAE Pneumonia Vaccines Market
7.4.5.3.1 UAE Pneumonia Vaccines Market by Vaccine Type
7.4.5.3.2 UAE Pneumonia Vaccines Market by Product Type
7.4.5.3.3 UAE Pneumonia Vaccines Market by Sector
7.4.5.3.4 UAE Pneumonia Vaccines Market by Distribution Channel
7.4.5.4 Saudi Arabia Pneumonia Vaccines Market
7.4.5.4.1 Saudi Arabia Pneumonia Vaccines Market by Vaccine Type
7.4.5.4.2 Saudi Arabia Pneumonia Vaccines Market by Product Type
7.4.5.4.3 Saudi Arabia Pneumonia Vaccines Market by Sector
7.4.5.4.4 Saudi Arabia Pneumonia Vaccines Market by Distribution Channel
7.4.5.5 South Africa Pneumonia Vaccines Market
7.4.5.5.1 South Africa Pneumonia Vaccines Market by Vaccine Type
7.4.5.5.2 South Africa Pneumonia Vaccines Market by Product Type
7.4.5.5.3 South Africa Pneumonia Vaccines Market by Sector
7.4.5.5.4 South Africa Pneumonia Vaccines Market by Distribution Channel
7.4.5.6 Nigeria Pneumonia Vaccines Market
7.4.5.6.1 Nigeria Pneumonia Vaccines Market by Vaccine Type
7.4.5.6.2 Nigeria Pneumonia Vaccines Market by Product Type
7.4.5.6.3 Nigeria Pneumonia Vaccines Market by Sector
7.4.5.6.4 Nigeria Pneumonia Vaccines Market by Distribution Channel
7.4.5.7 Rest of LAMEA Pneumonia Vaccines Market
7.4.5.7.1 Rest of LAMEA Pneumonia Vaccines Market by Vaccine Type
7.4.5.7.2 Rest of LAMEA Pneumonia Vaccines Market by Product Type
7.4.5.7.3 Rest of LAMEA Pneumonia Vaccines Market by Sector
7.4.5.7.4 Rest of LAMEA Pneumonia Vaccines Market by Distribution Channel

Chapter 8. Company Profiles
8.1 GLAXOSMITHKLINE PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Collaboration, partnerships and agreements:
8.1.1.2 Expansion:
8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Collaboration, partnerships and agreements:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Collaboration, partnerships and agreements:
8.4.5.2 Product launch:
8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
8.8.1 Company overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Collaboration, partnerships and agreements:
8.10.5.2 Product launch:
8.10.6 SWOT Analysis
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Glaxosmithkline Plc. (GSK)
  • LG Corporation
  • Panacea Biotec Limited
  • Pfizer, Inc.
  • Pnuvax Incorporated
  • Poonawalla Investments & Industries Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Holdings Co., Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Merck & Co., Inc.
Note: Product cover images may vary from those shown
Adroll
adroll